Projects per year
Fingerprint
Dive into the research topics where Department of Basic and Translational Oncology and Hematology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
JAK2 inhibitors: JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Kollmann, K. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.01.2022 → 31.12.2026
Project: Funded Research
-
APOG: ACCESS POINT Oncology
Podar, K. (PI), Stoiber-Sakaguchi, D. (CoPI), Pecherstorfer, M. (CoPI), Georg, P. (CoPI), Kieseberg, P. (CoPI), Fossati, P. (CoPI), Lütgendorf-Caucig, C. (CoPI) & Slade, D. (CoPI)
01.01.2020 → 31.12.2026
Project: Funded Research
-
Biomarker: Biomarker- based therapeutic prevention of bone metastases in breast cancer. Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI), Podar, K. (CoI) & Wiesner, C. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.12.2019 → 31.12.2023
Project: Funded Research
Research output
-
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia
Weiss, S., Zdársky, B., Witalisz-Siepracka, A., Edtmayer, S., Holzer, A., Heindl, K., Casanova, E., Podar, K. & Stoiber, D., 24 Jan 2025, (E-pub ahead of print) In: Cancer Letters. 613, p. 217501 217501.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy
Meli, R., Aksoy, O., Vallet, S., Slade, D. & Podar, K., 23 Mar 2025, (E-pub ahead of print) In: Expert Opinion on Therapeutic Targets.Research output: Journal article (peer-reviewed) › Journal article
-
Carbon-Ion Radiotherapy for Head and Neck Mucosal Melanoma: Preliminary Clinical Outcomes and the MedAustron Approach for Reporting RBE-Weighted Dose With 2 Models
Nachankar, A., Pelak, M., Schafasand, M., Martino, G., Tubin, S., Hug, E., Carlino, A., Lütgendorf-Caucig, C., Stock, M. & Fossati, P., Mar 2025, In: International Journal of Particle Therapy. 15, p. 100738 100738.Research output: Journal article (peer-reviewed) › Journal article
Open Access
Prizes
-
Posterpreis bei OeGHO Kongress
Gassner, T. (Recipient), Apr 2023
Prize: Other distinction › Poster prize
-
Preis für Best Submitted Abstract bei OeGHO Kongress
Aksoy, O. (Recipient), Apr 2023
Prize: Other distinction › Other
-
Wissenschaftspreis des Landes Niederösterreich 2022
Vallet, S. (Recipient), 2022
Prize: Honorary award
-
European Society for Medical Oncology (External organisation)
Vallet, S. (Member)
2022 → …Activity: Membership
-
Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie (OeGHO) (External organisation)
Vallet, S. (Member)
2022Activity: Membership
-